Indivior UK Limited
Records under this name other than the patents Indivior UK Limited holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 47 patents it holds.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,010,612 | Sustained delivery formulations of risperidone compounds Formerly held In force · USPTO record | In force | USPTO record | |
| US 12,290,596 | Compositions and Methods for the Treatment of Opioid Overdose Held by another company In force · High confidence | In force | High confidence | |
| US 11,110,093 | Sustained release small molecule drug formulation Term ended Term ended Nov 5, 2026 · USPTO record | Term ended | Term ended Nov 5, 2026 | USPTO record |
| US 9,044,450 | Sustained Release Small Molecule Drug Formulation Term ended Ended no later than Sep 26, 2026 · Low confidence | Term ended | Ended no later than Sep 26, 2026 | Low confidence |
| US 9,597,402 | Sustained release small molecule drug formulation Term ended Ended no later than Sep 26, 2026 · USPTO record | Term ended | Ended no later than Sep 26, 2026 | USPTO record |
| US 10,058,554 | Sustained release small molecule drug formulation Term ended Ended no later than Sep 26, 2026 · USPTO record | Term ended | Ended no later than Sep 26, 2026 | USPTO record |
| US 10,406,160 | Sustained release small molecule drug formulation Term ended Ended no later than Sep 26, 2026 · USPTO record | Term ended | Ended no later than Sep 26, 2026 | USPTO record |
| US 7,429,668 | Method and Intermediates for the Preparation of Derivatives of N (1-Benzhydrylazetidin-3-YL)-N-PHENYLMETHYLSULFONAMIDE Term ended Term ended Oct 10, 2025 · High confidence | Term ended | Term ended Oct 10, 2025 | High confidence |
| US 7,652,154 | Method and Intermediates for the Preparation of Derivatives of N (1-Benzhydrylazetidin-3-YL)-N-PHENYLMETHYLSULFONAMIDE Term ended Term ended Oct 10, 2025 · Medium confidence | Term ended | Term ended Oct 10, 2025 | Medium confidence |
| US 8,071,788 | Method and Intermediates for the Preparation of Derivatives of N (1-Benzhydrylazetidin-3-YL)-N-PHENYLMETHYLSULFONAMIDE Term ended Term ended Oct 10, 2025 · Medium confidence | Term ended | Term ended Oct 10, 2025 | Medium confidence |